Fig. 1 · Structure

Documents & Downloads

Zidovudine

Cat. No. A15428 CAS 30516-87-1

NRTI Inhibitor

Zidovudine is a nucleoside analog reverse-transcriptase inhibitor (NRTI), a type of antiretroviral drug used for the treatment of HIV/AIDS infection. Azidothymidine decreases CRISPR-mediated homology directed repair (HDR) efficiency.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
Reverse transcriptase

Cellular Effect

Cell Line Activity Value Description Reference
143B IC50 12.25 μM Cytotoxicity against human 143B cells after 72 hrs by MTT assay [PMID: 25440502]
143B IC50 148.42 μM Cytotoxicity against human thymidine kinase-deficient 143B cells after 72 hrs by MTT assay [PMID: 25440502]
5637 IC50 128.82 μM Antiproliferative activity in human 5637 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay [PMID: 30108758]
5637 IC50 7 μM Cytotoxicity against human 5637 cells assessed as growth inhibition after 48 hrs by MTT assay [PMID: 25811955]
A549 IC50 0.011 μM Inhibition of Influenza A virus (A/Viet Nam/1203/2004(H5N1)) hemagglutininin-mediated viral entry into human A549 cells assessed as luciferase activity after 48 hrs postinfection by luminometry [PMID: 19537689]
A549 IC50 0.012 μM Inhibition of Influenza A virus (A/Bar-headed Goose/Qinghai/59/05(H5N1)) hemagglutininin-mediated viral entry into human A549 cells assessed as luciferase activity after 48 hrs postinfection by luminometry [PMID: 19537689]
A549 IC50 11.86 μM Cytotoxicity in human A549 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay [PMID: 31400940]
A549 IC50 16.19 μM Cytotoxicity against human A549 cells after 48 hrs by SRB method [PMID: 25933593]
AA5 IC50 < 0.0003 μM Antiviral activity against of Human immunodeficiency virus 1 3B infected in AA5 cells infected with 1.56 uL of virus stock assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay [PMID: 20086149]
AA5 IC50 > 0.1 μM Cytotoxicity against human AA5 cells by MTS assay [PMID: 20086149]
AA5 IC50 0.0003 μM Antiviral activity against of Human immunodeficiency virus 1 3B infected in AA5 cells infected with 0.78 uL of virus stock assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay [PMID: 20086149]
AA5 IC50 0.0004 μM Antiviral activity against of Human immunodeficiency virus 1 3B infected in AA5 cells infected with 3.13 uL of virus stock assessed as inhibition of viral Reverse transcriptase by [3H]TTP incorporation assay [PMID: 20086149]
AA5 IC50 0.006 μM Antiviral activity against Human immunodeficiency virus 1 3B infected in AA5 cells infected with 0.78 uL of virus stock assessed as expression of p24 antigen after 6 days postinfection by ELISA [PMID: 20086149]
AA5 IC50 0.008 μM Antiviral activity against Human immunodeficiency virus 1 3B infected in AA5 cells infected with 3.13 uL of virus stock assessed as expression of p24 antigen after 6 days postinfection by ELISA [PMID: 20086149]
AA5 IC50 0.009 μM Antiviral activity against Human immunodeficiency virus 1 3B infected in AA5 cells infected with 1.56 uL of virus stock assessed as expression of p24 antigen after 6 days postinfection by ELISA [PMID: 20086149]
B(EBV+) EC50 0.001 μM Effective concentration required for antiviral activity against B(EBV+) cell line of AA5 cells of Human by XTT assay [PMID: 7932526]
Bel-7402 EC50 4.62 μM Cytotoxicity against human Bel7402 cells after 48 hrs by MTT assay [PMID: 18313175]
Bone marrow cell CC50 0.5 μM Cytotoxicity against human bone marrow cells after 24 hrs by BFU-E assay [PMID: 20439609]
Bone marrow cell CC50 0.89 μM Cytotoxicity against human bone marrow cells after 24 hrs by GM-CFU assay [PMID: 20439609]

19 records · Scroll to view more

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 30516-87-1
Applications NRTI Inhibitor
Formula C10H13N5O4
Molecular Weight 267.3
Synonyms Azidothymidine; AZT; ZDV
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-]

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 50 mg/mL (187.09 mM)
Water Warmed: 50 mg/mL (187.09 mM)
Ethanol Warmed: 17 mg/mL (63.61 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...